Compare · head to head
JW vs JW Pharmaceutical
JW ranks higher overall — 360 rank 97 vs 95.
JW leads on Quality (84 vs 74) and Sentiment (53 vs 45). JW Pharmaceutical leads on Safety (61 vs 44). The two are close on Value and Growth.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Small |
| ISIN | KR7096760004 | KR7001060003 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 97 | 95 |
| Value | 71 | 69 |
| Quality | 84 | 74 |
| Growth | 58 | 56 |
| Safety | 44 | 61 |
| Sentiment | 53 | 45 |
| Quality details | ||
| Profitability | 92 | 92 |
| Cash Truth | 75 | 55 |
JW vs Kwangdong PharmaceuticalJW vs Kukje PharmaJW vs Jeil PharmaJW vs Ildong HoldingsAdd a third stock →
Full analyses: JW · JW Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100